CME/CE

Use the tool below to view all available Prova Series

Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
CME/CE
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
0.25 credits
- Darren Brenner, MD
0.25 credits
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
CME/CE
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
1.00 credit
- Robert D. Suh, MD
- Lea Azour, MD
- Ashwin Basavaraj, MD
1.00 credit
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
CME/CE
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
0.25 credits
- Neal Shore, MD, FACS
- Sarah Psutka, MD, MS
0.25 credits
CME/CE Meeting
Acromegaly Care: Individualized Diagnosis and Management Strategies
July 13, 2025
San Francisco, California
1.50 credits Learn more
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
CME/CE
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
0.25 credits
- Kendall Moseley, MD
- Kenneth G. Saag, MD
0.25 credits
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
CME/CE
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
0.50 credits
- Marilyn Yuanxin Ma Bui, MD, PhD
- Anne Vincent-Salomon, MD
0.50 credits
Ocular to Generalized MG: How and Why the Disease Evolves
Ocular to Generalized MG: How and Why the Disease Evolves
MinuteCE®
Ocular to Generalized MG: How and Why the Disease Evolves
1.00 program credit
- Vera Bril, MD
- Hans Katzberg, MD
1.00 program credit
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
CME/CE
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
0.75 credits
- Vera Bril, MD
- Jonathan Strober, MD
0.75 credits
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
MinuteCE®
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
1.00 program credit
- Vera Bril, MD
- Nicholas J. Silvestri, MD
1.00 program credit
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Managing Side Effects in FcRn Therapy: Best Practices for gMG
MinuteCE®
Managing Side Effects in FcRn Therapy: Best Practices for gMG
1.00 program credit
- Vera Bril, MD
- Nicholas J. Silvestri, MD
1.00 program credit
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
MinuteCE®
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
1.00 program credit
- Vera Bril, MD
- Nicholas J. Silvestri, MD
1.00 program credit
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
MinuteCE®
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
1.00 program credit
- Vera Bril, MD
- Nicholas J. Silvestri, MD
1.00 program credit
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
MinuteCE®
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
1.00 program credit
- Vera Bril, MD
- Nicholas J. Silvestri, MD
1.00 program credit
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Collaborative Insights to Solve the Puzzle of Bladder Cancer
CME/CE
Collaborative Insights to Solve the Puzzle of Bladder Cancer
1.00 credit
- Daniel P. Petrylak, MD
- Elizabeth R. Plimack, MD, MS, FASCO
- Evan Y. Yu, MD
1.00 credit
What’s New in Suprachoroidal MIGS?
What’s New in Suprachoroidal MIGS?
MinuteCE®
What’s New in Suprachoroidal MIGS?
1.00 program credit
- I. Paul Singh, MD
- Paul Petrakos, DO, MS
1.00 program credit
What’s New in Glaucoma Topical Therapies?
What’s New in Glaucoma Topical Therapies?
MinuteCE®
What’s New in Glaucoma Topical Therapies?
1.00 program credit
- Justin Schweitzer, OD, FAAO
- Sarah H. Van Tassel, MD
1.00 program credit

CME/CE

Popular

Title

Share on ReachMD